Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.
Iijima R, Kougame N, Hara H, Moroi M, Nakamura M.
Circ J. 2018 Jul 25;82(8):2025-2031. doi: 10.1253/circj.CJ-18-0121. Epub 2018 Jun 12.
Angioscopic findings 1 year after percutaneous coronary intervention for chronic total occlusion.
Fukuizumi I, Tokita Y, Shiomura R, Noma S, Matsuda J, Sangen H, Kubota Y, Komiyama H, Nakata J, Miyachi H, Tara S, Shimizu W, Yamamoto T, Takano H.
J Cardiol. 2023 Jan;81(1):91-96. doi: 10.1016/j.jjcc.2022.08.008. Epub 2022 Sep 1.
Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms.
Scarparo P, Schermers T, Improta R, Kardys I, Wilschut J, Daemen J, Nuis RJ, Den Dekker WK, Van Mieghem NM, Diletti R.
Catheter Cardiovasc Interv. 2023 Sep;102(3):451-463. doi: 10.1002/ccd.30774. Epub 2023 Aug 1.
Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions.
Kelbæk H, Yeh RW, Engstrøm T, Neumann FJ, Serruys PW, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S.
EuroIntervention. 2021 Mar 19;16(16):1326-1332. doi: 10.4244/EIJ-D-19-00866.
Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry.
Suwannasom P, Athiksakul S, Thonghong T, Lertsuwunseri V, Chaipromprasit J, Srimahachota S, Udayachalerm W, Kuanprasert S, Buddhari W.
BMC Cardiovasc Disord. 2021 Oct 16;21(1):501. doi: 10.1186/s12872-021-02310-0.
Perspectives of drug-eluting stents: the next revolution.
Moses JW, Kipshidze N, Leon MB.
Am J Cardiovasc Drugs. 2002;2(3):163-72. doi: 10.2165/00129784-200202030-00004.
Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial.
Somsen YBO, de Winter RW, Wu J, Hoek R, Sprengers RW, Verouden NJ, Claessen BEPM, Kleijn SA, Twisk JWR, Henriques JP, Spratt JC, Rissanen TT, McEntegart MB, Maehara A, Nap A, Knaapen P.
Am Heart J. 2025 Apr 7:S0002-8703(25)00105-X. doi: 10.1016/j.ahj.2025.03.023. Online ahead of print.
Double-barrel coronary artery after subintimal stenting for chronic total occlusion.
Watanabe Y, Fujino Y, Ishiguro H, Nakamura S.
Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):361-363. doi: 10.1016/j.carrev.2016.10.010. Epub 2016 Oct 30.
Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
Jia H, Hu S, Liu H, Zhu Y, Zhe CY, Li L, Mustafina I, Hou J, Zhang S, Yu B.
Catheter Cardiovasc Interv. 2017 Mar;89(S1):582-591. doi: 10.1002/ccd.26969.
